BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10831033)

  • 1. Failure to consider drug-drug interactions as a likely cause of behavioral deterioration in a patient with bipolar disorder.
    Shad U; Preskorn SH; Izgur Z
    J Clin Psychopharmacol; 2000 Jun; 20(3):390-2. PubMed ID: 10831033
    [No Abstract]   [Full Text] [Related]  

  • 2. A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder.
    Guille C; Sachs GS; Ghaemi SN
    J Clin Psychiatry; 2000 Sep; 61(9):638-42. PubMed ID: 11030483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olanzapine and negative symptoms.
    Rosen EH
    J Clin Psychiatry; 1998 Oct; 59(10):537-8. PubMed ID: 9818636
    [No Abstract]   [Full Text] [Related]  

  • 4. Possible induction of mania and hypomania by olanzapine or risperidone: a critical review of reported cases.
    Aubry JM; Simon AE; Bertschy G
    J Clin Psychiatry; 2000 Sep; 61(9):649-55. PubMed ID: 11030485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olanzapine-induced mania in bipolar disorders.
    Henry C; Demotes-Mainard J
    J Psychiatry Neurosci; 2002 May; 27(3):200-1. PubMed ID: 12066449
    [No Abstract]   [Full Text] [Related]  

  • 6. Olanzapine and risperidone.
    Love RC; Kelly DL
    Am J Health Syst Pharm; 2003 Mar; 60(5):487-8; author reply 488-9. PubMed ID: 12635459
    [No Abstract]   [Full Text] [Related]  

  • 7. Return of menstruation after switching from risperidone to olanzapine.
    Gazzola LR; Opler LA
    J Clin Psychopharmacol; 1998 Dec; 18(6):486-7. PubMed ID: 9864085
    [No Abstract]   [Full Text] [Related]  

  • 8. Rapid efficacy of olanzapine augmentation in nonpsychotic bipolar mixed states.
    Ketter TA; Winsberg ME; DeGolia SG; Dunai M; Tate DL; Strong CM
    J Clin Psychiatry; 1998 Feb; 59(2):83-5. PubMed ID: 9501894
    [No Abstract]   [Full Text] [Related]  

  • 9. Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial.
    Rosenheck R; Perlick D; Bingham S; Liu-Mares W; Collins J; Warren S; Leslie D; Allan E; Campbell EC; Caroff S; Corwin J; Davis L; Douyon R; Dunn L; Evans D; Frecska E; Grabowski J; Graeber D; Herz L; Kwon K; Lawson W; Mena F; Sheikh J; Smelson D; Smith-Gamble V;
    JAMA; 2003 Nov; 290(20):2693-702. PubMed ID: 14645311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New treatments for bipolar disorder: the role of atypical neuroleptic agents.
    Ghaemi SN
    J Clin Psychiatry; 2000; 61 Suppl 14():33-42. PubMed ID: 11154015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comments on "Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders" by Tran and Associates.
    Kasper S; Küfferle B
    J Clin Psychopharmacol; 1998 Aug; 18(4):353-6. PubMed ID: 9690709
    [No Abstract]   [Full Text] [Related]  

  • 12. Olanzapine for mixed episodes of bipolar disorder.
    Zullino D; Baumann P
    J Psychopharmacol; 1999; 13(2):198. PubMed ID: 10475728
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of bipolar I disorder in an adolescent with olanzapine.
    Khouzam HR; El-Gabalawi F
    J Child Adolesc Psychopharmacol; 2000; 10(2):147-51. PubMed ID: 10933124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective treatment of mania with olanzapine: 2 case reports.
    Ravindran AV; Jones BW; al-Zaid K; Lapierre YD
    J Psychiatry Neurosci; 1997 Nov; 22(5):345-6. PubMed ID: 9401315
    [No Abstract]   [Full Text] [Related]  

  • 15. Olanzapine and benztropine as a cause of ischemic colitis in a 27-year-old man.
    Park SJ; Gunn N; Harrison SA
    J Clin Gastroenterol; 2012 Jul; 46(6):515-7. PubMed ID: 22011585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperprolactinemia and male sexual dysfunction.
    Dickson RA; Glazer WM
    J Clin Psychiatry; 1999 Feb; 60(2):125. PubMed ID: 10084644
    [No Abstract]   [Full Text] [Related]  

  • 17. Weight gain and antipsychotic medications.
    Aquila R; Emanuel M
    J Clin Psychiatry; 1999 May; 60(5):336-7. PubMed ID: 10362443
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of risperidone and olanzapine on the indications for clozapine.
    Ganguli R; Brar JS
    Psychopharmacol Bull; 1998; 34(1):83-7. PubMed ID: 9564203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotic agents and bipolar disorder.
    Tohen M; Zarate CA
    J Clin Psychiatry; 1998; 59 Suppl 1():38-48; discussion 49. PubMed ID: 9448668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical antipsychotics and cardiovascular risk in schizophrenic patients.
    Bouchard RH; Demers MF; Simoneau I; Alméras N; Villeneuve J; Mottard JP; Cadrin C; Lemieux I; Després JP
    J Clin Psychopharmacol; 2001 Feb; 21(1):110-1. PubMed ID: 11199934
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.